This biotechnology company specializes in the early diagnosis of ocular pathologies through the use of specific biomarkers, focusing on corneal diseases. By developing targeted treatments, the company aims to enhance corneal integrity and improve patients' quality of life.
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AOFounders
Product
Problem
Keratoconus and Dry Eye Syndrome are progressive corneal diseases that can lead to significant vision loss if not diagnosed and treated early. Traditional diagnostic methods often lack the sensitivity to detect these conditions in their initial stages, limiting effective intervention.
Solution
CORNEA_project is developing innovative Point-of-Care (PoC) devices based on molecular biomarkers for the early diagnosis and prognosis of corneal diseases. Their KERAPOC project focuses on keratoconus, utilizing a minimally invasive method for collecting corneal epithelial samples and integrating advanced molecular analysis technologies to detect the disease early and predict its progression. The KERASOS project addresses Dry Eye Syndrome by identifying biomarkers to differentiate subtypes of the disease, enabling more precise and personalized treatment plans. These technologies aim to improve diagnostic accuracy, personalize treatment, and enhance the quality of life for patients affected by corneal disorders.
Target Audience
The primary target audience includes ophthalmologists and optometrists seeking advanced diagnostic tools for early detection and personalized treatment of corneal diseases like keratoconus and Dry Eye Syndrome.
Features
- Point-of-Care (PoC) devices for rapid and accurate diagnosis in clinical settings
- Minimally invasive method for collecting corneal epithelial samples
- Multiplexed system for simultaneous assessment of multiple biomarkers
- Molecular biomarker-based approach for early disease detection and prognosis
- Technologies for differentiating subtypes of Dry Eye Syndrome (e.g., evaporative and aqueous-deficient)
- Patented advanced molecular analysis methods